dr. goodman on the importance of the echelon-2 data in ptcl
Published 4 years ago • 79 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
0:55
dr. goodman on contributing factors to the lack of development in ptcl treatment
-
4:17
echelon-2 trial updates and the role of transplant in cd30-positive ptcl
-
0:46
dr. goodman on the need for molecular subtyping in t-cell lymphomas
-
3:19
the impact of brentuximab vedotin as ptcl treatment
-
1:11
dr. goodman on the role of pd-1 inhibitors in t-cell lymphomas
-
2:03
5-year follow-up of echelon-2: a chp vs chop for cd30 ptcl
-
1:47
lorenz trumper, md, discusses the results of echelon-2 in frontline ptcl
-
59:32
prof. glen jeffrey | red light revolution: charge your cells, reduce ageing & decrease inflammation
-
4:24
s -2 - ms - e - 3 - gut is the heaven
-
48:16
wonder of the cell - dr. georgia purdom
-
2:07
dr. goodman on the role of transplant in t-cell lymphoma
-
2:10
tatyana feldman, md, offers opinion on the echelon-2 study in ptcl
-
1:46
dr. horwitz discusses the results of the echelon-2 study
-
3:22
the echelon-2 trial presented at ash 2018
-
2:44
brentuximab vedotin and chp for ptcl: upcoming phase ii trial
-
2:01
the "inflection point" in medicine
-
1:32
echelon-2: brentuximab vedotin and chp for cd30-positive t-cell lymphomas
-
2:23
swaminathan padmanabhan iyer, md, on if echelon-2 study is game changing for patients with ptcl
-
3:25
echelon-1 trial: significance in hodgkin lymphoma
-
12:46
richard goodman: inter-cellular and intra-cellular transfer of amr genes in bacteria
-
3:34
echelon-2: study into rentuximab vedotin and chp versus chop in the frontline treatment of patie...
-
2:18
radhakrishnan ramchandren, md, offers opinion on the echelon-2 trial as presented at ash 2020